FierceBiotech 2026年5月14日 BioAge CEO has big plans for 'multi-disease impact' of NLRP3 drug across cardio, ocular and CNS
FierceBiotech 2026年5月14日 Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?
FierceBiotech 2026年5月14日 Aptose, facing cash crunch, exits blood cancer pact after Hanmi buyout blocks development
FierceBiotech 2026年5月13日 Icon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities
FierceBiotech 2026年5月13日 Humacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant
FierceBiotech 2026年5月13日 With $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’
FierceBiotech 2026年5月13日 Valneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines
FierceBiotech 2026年5月13日 Medtronic to shutter Santa Rosa plant as it restructures cardio vascular unit